Oncogenomics of Multiple Myeloma and Related Disorders
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (15 July 2021) | Viewed by 304
Special Issue Editors
Interests: multiple myeloma; genetics; transcription
Interests: long noncoding RNA (lncRNA); microRNA (miRNA); multiple myeloma; plasma cell dyscrasias; RNA therapeutics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Sequencing and editing of the cancer genome and epigenome have provided unprecedented views of oncogenic genetic circuitries and networks underlying the disease. Multiple Myeloma (MM) is a highly heterogenous and complex disease characterized by accumulation of various genetic and epigenetic abnormalities that drive the malignant phenotype and impact response to therapy and disease outcome.
This special issue will focus on the current understanding of genetic, epigenetic and transcriptional alterations of MM and its precursor conditions, and the translational potential of novel therapeutics that target key gene circuits in MM.
We invite authors to contribute original research articles as well as review articles. Potential topics include, but are not limited to:
- Genetic, epigenetic and transcriptional landscape of MM and other plasma cell dyscrasias.
- Genetic alterations in the pathobiology of MM
- Epigenetic alterations and factors in the pathobiology of the disease
- Transcriptional and post-transcriptional control in MM and other plasma cell dyscrasias.
- Noncoding RNAs as biomarkers and potential targets for gene therapy.
- Genome instability in MM disease progression and prognosis.
Dr. Mariateresa Fulciniti
Dr. Eugenio Morelli
Dr. Mehmet Kemal Samur
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Multiple myeloma
- Plasma cell dyscrasias
- Transcriptional regulation
- Genomic Instability
- Prognosis
- Noncoding RNA
- DNA Sequencing
- RNA Sequencing
- Single Cell Sequencing
- Epigenetic
- Alternative splicing
- RNA therapeutics
- Genomics
- Epigenomics
